Member Info for RorkesDrift

Yep pg/ml but

If one molucule weighs 300pg then at 300pg/ml there is one molecule and therefore one potential binding reaction

If protein molecule weighs 30pg then at 300pg/ml there are 10 possible binding reactions. And so on. Its the number of molecules rather then their weight per ml.

Increasing the density of the affirmers might influence this - that is one advantage that affirmers have over Abs because of their smaller size. The Deepverge test probably relies on this to increase sensitivity.

Revenue from, well anything

I confess I ended up relenting and because I miss the little fellah (he is 5 foot 2 you know) had a look at his lordships twit feed. Noting that he has reciprocated and is an avid reader of these pages I tug my for lock and shuffle nervously. I look down but from the corner of my eye I feel more than see him pulling out his battering sausage.

Anyway having played the Pied Piper on behalf of the Avacta Timeline (Done I hear you cry) the self anulted one has only gone and jinxed another one of stocks. Declaring he has taken a position (oooh err, nudge nudge) in Deep verge the bloody thing has failed to recover ever since. I really hope he moves back to his more familiar and comfortable place if tulip bulbs and square cannon balls.

I'd send him a Christmas card ifvi could but hey

My biochemistry is not up to it. If a protein weighs twice as much as another then at 300pg there will be twice as much in one as another. Kinetics suggest that affinity is related to concentration. I'm going to stop there cause I'm already confused.

https://youtu.be/kfdpcrOgUp4

Deep verge.

Be having a pop at the Easter Bunny next

I am sure he mention something about Poland at one point

Date wrong

https://link.springer.com/article/10.1007/s00430-020-00668-0

If anyone fancies doing a PhD - advert for Bath.

Sepsis is “a life threatening condition that arises when the body's response to an infection injures its own tissues and organs”. Striking with equal ferocity in both the developed and developing worlds,
sepsis kills one person every few seconds.

In the UK alone, it kills more people than breast, bowel and prostate cancer combined.

Unfortunately, clinical symptoms, such as raised temperature, increased pulse or breathing rate, and current laboratory diagnostics, such as white blood cell count or bacterial culture are relatively non specific and lack the sensitivity necessary for a definitive early diagnosis. There is a critical and unmet clinical need to develop diagnostic technologies capable of rapidly and accurately diagnosing sepsis.

For every hour delay in diagnosis, the risk of death increases by 6-10%.
Researchers at the Universities of Bath and Cardiff have jointly developed exciting new approaches for the detection of disease associated biomarkers. Using carefully designed synthetic recognition
systems coupled with simple, yet elegant, electrochemical sensing approaches, we have demonstrated the ability to detect biomarkers in clinical samples with excellent sensitivity and selectivity.

Is in us?

@livelongandprosper. The multiplex stuff would take us to next level - all sorts of diseases have complex patterns - Avacta already looking at Sepsis (I'll resist .....)

If they prove this approach in real world clinical application then TO would be on cards. DX not as valuable as TX but could spin one arm off and keep the other.

If you have ever read one of these reports they are hilarious. My company was reported as having sales 10x more than we did - only discovered cause a potential investor kept quoting it. I rang them up to ask them their methodology and it was basically calculate maximum market size from disease incidence and allocate to different companies based on how slick their website was.

Lol could you imagine. PL starts off every question with "and another thing....."

We then move to questions from the audience.

Global would like to suggest..

DOH can beat any quote you get on the new pad...

RD wants to know what you recommend at the Weatherby Whaler.

On that I have to thank whoever it was all those months ago who said they spotted him in there. Avacta LSE folklore.

I hope you are right. As shareholders I think the first order of business at the AGM should be who does the interviews. Giles and the lady at proactive are OK but the bloke who sounds like Julian Clarey gets my vote.

I suspect his knees are hurting, what with all that kneeling down at the docks.

On a minor point you don't need to be listed to have share holders. Otherwise my net worth has just taken a serious dent.

Secondly I apologise for calling Vegas out of the closet following his mock homo phobia but really the knee jerk reaction needs a bit of sprucing up. Just blah blah blah each time is letting the board down, its letting his lordship down but most of all....

Thirdly most share price sensitive info is better disclosed that not. I believe there may even be rules about it.

I hear the sound

Of distant hooves

Far away, far away

(Clip clop clip clop)

We hear lots of news about other companies. For example Sure Screen.

I don't hear them using NDA as a reason for not communication with shareholders. Why would there be an NDA in place - its not like we are asking to hear anything of IP value or commercially advantageous - competition know our science

My assumption is Prof Waffle has over promised even if that's just timelines but he needs to grow a pair and Profess up.

Fingers crossed

How I long for a yank